Accurate analysis of genuine CRISPR editing events with ampliCan
- Kornel Labun1,
- Xiaoge Guo2,3,
- Alejandro Chavez4,
- George Church2,3,
- James A. Gagnon5 and
- Eivind Valen1,6
- 1Department of Informatics/Computational Biology Unit, University of Bergen, Bergen 5008, Norway;
- 2Wyss Institute for Biologically Inspired Engineering, Harvard University, Cambridge, Massachusetts 02115, USA;
- 3Department of Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA;
- 4Department of Pathology and Cell Biology, Columbia University, New York, New York 10032, USA;
- 5Department of Biology, University of Utah, Salt Lake City, Utah 84112, USA;
- 6Sars International Centre for Marine Molecular Biology, University of Bergen, Bergen 5008, Norway
Abstract
We present ampliCan, an analysis tool for genome editing that unites highly precise quantification and visualization of genuine genome editing events. ampliCan features nuclease-optimized alignments, filtering of experimental artifacts, event-specific normalization, and off-target read detection and quantifies insertions, deletions, HDR repair, as well as targeted base editing. It is scalable to thousands of amplicon sequencing–based experiments from any genome editing experiment, including CRISPR. It enables automated integration of controls and accounts for biases at every step of the analysis. We benchmarked ampliCan on both real and simulated data sets against other leading tools, demonstrating that it outperformed all in the face of common confounding factors.
Footnotes
-
[Supplemental material is available for this article.]
-
Article published online before print. Article, supplemental material, and publication date are at http://www.genome.org/cgi/doi/10.1101/gr.244293.118.
-
Freely available online through the Genome Research Open Access option.
- Received September 16, 2018.
- Accepted February 25, 2019.
This article, published in Genome Research, is available under a Creative Commons License (Attribution 4.0 International), as described at http://creativecommons.org/licenses/by/4.0/.